The clinical content of preconception care: women with chronic medical conditions

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 6 SUPPL. B, 2008, Pages

  Dunlop, Anne L ^a   Jack, Brian W ^b   Bottalico, Joseph N ^c   Lu, Michael C ^d   James, Andra ^e   Shellhaas, Cynthia S ^f,g   Hallstrom, Lynne Haygood Kane ^h   Solomon, Benjamin D ⁱ   Feero, W Gregory ⁱ   Menard, M Kathryn ^j   Prasad, Mona R ^f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c University of Medicine and Dentistry   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g Family Health Services   (United States)

^h TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

chronic; medical condition; preconception

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BARBITURIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CONTRACEPTIVE AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; ETHINYLESTRADIOL; FOLIC ACID; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; METHYLDOPA; METOPROLOL; OXPRENOLOL; PHENYTOIN; PINDOLOL; PROPYLTHIOURACIL; THYROXINE; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID;

ASTHMA; BIRTH WEIGHT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLEFT FACE; CLEFT LIP PALATE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTRACEPTION; DEVELOPMENTAL DISORDER; DIETARY INTAKE; DISEASE COURSE; DRUG MEGADOSE; EPILEPSY; FACE MALFORMATION; FETUS DEATH; FETUS DISEASE; FETUS MALFORMATION; HEART DISEASE; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; LIFESTYLE MODIFICATION; LOW BIRTH WEIGHT; LOW DRUG DOSE; MATERNAL CARE; METABOLIC SYNDROME X; MONOTHERAPY; NEURAL TUBE DEFECT; NEWBORN HEMORRHAGIC DISEASE; NEWBORN SCREENING; OVARY POLYCYSTIC DISEASE; PERINATAL DEATH; PHENYLKETONURIA; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; PROGENY; REVIEW; RHEUMATOID ARTHRITIS; SCREENING TEST; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SKELETON MALFORMATION; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHILIA; THYROID DISEASE; TREATMENT DURATION; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

CHRONIC DISEASE; FEMALE; HUMANS; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE;

EID: 57149120023     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.08.031     Document Type: Review

References (203)

1. US Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. Women's Health USA 2002 (2002), US Department of Health and Human Services, Rockville, MD
2. Centers for Disease Control and Prevention. Recommendations to improve preconception health and health care-United States: a report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Morb Mortal Wkly Rep 55 (2006) 1-23
3. Moos M. Preconceptional health promotion: opportunities abound. Matern Child Health J 6 (2002) 71-73
4. Weisman C. Changing definitions of women's health: implications for health care and policy. Matern Child Health J 1 (1997) 179-189
5. Clancy C., and Massion C. American women's healthcare: a patchwork quilt with gaps. JAMA 268 (1992) 1918-1920
6. Allaire A., and Cefalo R. Preconceptional health care model. Obstet Gynecol Reprod Biol 78 (1998) 163-168
7. Frey K. Preconception care by the non-obstetrical provider. Mayo Clin Proc 77 (2002) 469-473
8. National Center for Health Statistics. Ambulatory health care data: NAMCS description (2004), US Department of Health and Human Services, Centers for Disease and Control and Prevention, National Center for Health Statistics, Washington, DC. http://www.cdc.gov/nchs/about/major/ahcd/namcsdes.htm Available from: http://www.cdc.gov/nchs/about/major/ahcd/namcsdes.htm. Accessed February 2, 2008
9. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol 105 (2005) 675-685
10. American Diabetes Association. Position statement, gestational diabetes mellitus. Diabetes care. Vol. 27, Suppl I, January 2004.
11. Kim C., Berger D.K., and Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 30 (2007) 1314-1319
12. Bottalico J.N. Recurrent gestational diabetes: risk factors, diagnosis, management, and implications. Semin Perinatol 31 (2007) 176-184
13. Verma A., Boney C., Tucker R., and Vohn B.R. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 87 (2002) 3227-3235
14. Kousta E., Lawrence N.J., Godsla I.F., et al. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol 59 (2003) 289-297
15. Lauenborg J., Mathiesen E., Hansen T., et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes is 3-fold higher than in the general population. J Clin Endocrinol Metab 90 (2005) 4004-4010
16. Peters R.K., Kjos S.L., Xiang A., and Buchanan T.A. Long term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347 (1996) 227-230
17. Ogden C.L., Carroll M.D., McDowell M.A., and Flegal K.M. Obesity among adults in the United States-no change since 2003-2004. NCHS data brief no 1 (2007), National Center for Health Statistics, Hyattsville, MD. http://www.cdc.gov/nchs/data/databriefs/db01.pdf Available from: http://www.cdc.gov/nchs/data/databriefs/db01.pdf. Accessed March 15, 2008
18. Kimm S., Glynn N.W., Kriska A.M., et al. Decline in physical activity in black girls and white girls during adolescence. N Engl J Med 347 (2002) 709
19. Reece E.A. Obesity, diabetes, and links to congenital defects: a review of the evidence and recommendations for intervention. J. Matern Fetal Neonatal Med 21 (2008) 173-180
20. Kitzmiller J.L., Buchanan T.A., Kjos S., Combs C.A., and Ratner R.E. Preconception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19 (1996) 514-541
21. Rosenn B., Miodovnik M., Combs C.A., Khoury J., and Siddiqi T.A. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 84 (1994) 515-520
22. Mills J.L., Simpson J.L., Driscoll S.G., et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319 (1988) 1617-1623
23. Taysi K. Preconceptional counseling. Obstet Gynecol Clin North Am 15 (1988) 167-178
24. Sheffield J.S., Butler-Koster E.L., Casey B.M., McIntire D.D., and Leveno K.J. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 100 (2002) 925-930
25. Russell M., Phipps M., Olson C., Welch H.G., and Carpenter M.W. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 8 (2006) 1456-1462
26. Standards of Medical Care in Diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
27. Kitzmiller J.L., Gavin L.A., Gin G.D., Jovanovic-Peterson L., Main E.K., and Zigrang W.D. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 265 (1991) 731-736
28. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
29. Buchanan T., Xiang A., Peters R.K., et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51 (2002) 2796-2803
30. Gerstein H., Yusuf S., Bosch J., et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 368 (2006) 1096-1105
31. Roland J.M., Murphy H.R., Ball V., Northcote-Wright J., and Temple R.C. The pregnancies of women with type 2 diabetes: poor outcomes but opportunities for improvement. Diabet Med 22 (2005) 1774-1777
32. Elixhauser A., Weschler J.M., and Kitzmiller J.L. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 16 (1993) 1146-1157
33. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care 27 (2004) S76-S78
34. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. (2004), World Health Organization, Geneva. http://www.whoint/reproductive-health/publications/mec/mec.pdf Available at: http://www.whoint/reproductive-health/publications/mec/mec.pdf. Accessed March 25, 2008
35. ParaGard T380A Intrauterine Copper Contraceptive [prescribing information] (2005), FEI Products, LLC, North Tonawanda, NY. http://www.paragard.com/paragard/custom_images/Prescribinginfo.pdf Available at: http://www.paragard.com/paragard/custom_images/Prescribinginfo.pdf. Accessed March 26, 2008
36. American Association of Clinical Endocrinologists, AACE Thyroid Task Force. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8 (2002) 457-469
37. Mestman J.H. Hyperthyroidism in pregnancy. Clin Obstet 40 (1997) 45-64
38. American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists: thyroid disease in pregnancy. Obstet Gynecol 100 (2002) 387-396
39. Klein R.Z., Haddow J.E., Faix J.D., et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 35 (1991) 41-46
40. Allan W.C., Haddow J.E., Palomaki G.E., et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 7 (2000) 127-130
41. Woeber K.A. Subclinical thyroid dysfunction. Arch Intern Med 157 (1997) 1065-1068
42. Canaris G.J., Manowitz N.R., Mayor G., and Ridgway E.C. The Colorado thyroid disease prevalence study. Arch Intern Med 160 (2000) 526-534
43. Davis L.E., Leveno K.J., and Cunningham F.G. Hypothyroidism complicating pregnancy. Obstet Gynecol 72 (1988) 108-112
44. Leung A.S., Millar L.K., Koonings P.P., Montoro M., and Mestman J.H. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 81 (1993) 349-353
45. Casey B.M., Dashe J.S., Wells C.E., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105 (2005) 239-245
46. Pop V.J., Kujpen J.L., van Baar A.L., Verkerk G., et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 50 (1999) 149-155
47. Pop V.J., Brouwers E.P., Vader H.L., Vulsma T., van Baar A.L., and de Vijlder J. Maternal hypothyroxinemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 59 (2003) 282-288
48. Haddow J.E., Palomaki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341 (1999) 549-555
49. Singer P.A., Cooper D.S., Levy E.G., et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 273 (1995) 808-812
50. Tan T.O., Cheng Y.W., and Caughey A.B. Are women who are treated for hypothyroidism at risk for pregnancy complications?. Am J Obstet Gynecol 194 (2006) e1-e3
51. Loriaux D.L., and Wild R.A. Contraceptive choices for women with endocrine complications. Am J Obstet Gynecol 168 Suppl 6 (1993) 2021-2026
52. Goldsmith R., Sturgis S., Lerman Y., and Stanbury J.B. The menstrual pattern in thyroid disease. J Clin Endocrinol Metab 12 (1952) 846-855
53. Mestman J.H., Godwin T.M., and Montoro M.M. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am 24 (1995) 41-71
54. National Institutes of Health. Phenylketonuria: screening and management. NIH Consensus Statement 17 (2000) 1-27
55. Koch R., Hanley W., Levy H., et al. The Maternal Phenylketonuria International Study: 1984-2002. Pediatrics 112 (2003) 1523-1529
56. Rouse B., and Azen C. Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy. J Pediatr 144 (2004) 235-239
57. Levy H.L., Waisbren S.E., Guttler F., et al. Pregnancy experiences in the woman with mild hyperphenylalaninemia. Pediatrics 112 (2003) 1548-1552
58. Walter J.H., White F.J., Hall S.K., et al. How practical are recommendations for dietary control in phenylketonuria?. Lancet 360 (2002) 55-57
59. American College of Obstetricians and Gynecologists Committee on Genetics. Maternal phenylketonuria. Int J Gynecol Obstet 72 (2001) 83-84
60. Drogari E., Smith I., Beasley M., and Lloyed J.K. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. Lancet 2 (1987) 927-930
61. Platt L.D., Koch R., Azen C., et al. Maternal phenylketonuria collaborative study, obstetric aspects and outcome: the first 6 years. Am J Obstet Gynecol 166 (1992) 1150-1162
62. Barrett C., and Richens A. Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Res 52 (2003) 147-187
63. American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 51 (1998) 944-948
64. Cantrell D.C., Riela S.J., Ramus R., and Riela A.R. Epilepsy and pregnancy: a study of seizure frequency and patient demographics (Abstract). Epilepsia 38 (1997) 231
65. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. ACOG educational bulletin: seizure disorders in pregnancy. Int J Gynaecol Obstet 56 (1997) 279-286
66. Morrell M.J. Guidelines for the care of women with epilepsy. Neurology 51 Suppl 4 (1998) S21-S27
67. Omtzigt J.G.C., Los F.J., Grobbee D.E., et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42 Suppl 5 (1992) 119-125
68. Koch S., Loesche G., Jager-Roman E., et al. Major and minor birth malformations and antiepileptic drugs. Neurology 42 Suppl 5 (1992) 83-88
69. Stern J.M. Overview of treatment guidelines for epilepsy. Curr Treat Options Neurol 8 (2006) 280-288
70. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomized study of antiepileptic drug withdrawal in patients in remission. Lancet 337 (1991) 1175-1180
71. Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment. Contraception 33 (1986) 559-565
72. Schappert S.M., and Burt C.W. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat 13 (2006) 1-66
73. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
74. Agency for Healthcare Research and Quality. Management of chronic hypertension during pregnancy. Evidence Report/Technology Assessment no.14. AHRQ publication no. 00-E011 (2000), Agency for Healthcare Research and Quality, Rockville, MD
75. Ferrer R.L., Sibai B.M., Mulrow C.D., Chiquette E., Stevens K.R., and Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 96 (2000) 849-860
76. Brown M.A., and Buddle M.L. Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 165 (1996) 360-365
77. McCowan L.M., Buist R.G., North R.A., and Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 103 (1996) 123-129
78. Sibai B.M., Abdella T.N., and Anderson G.D. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 61 (1983) 571-576
79. Sibai B.M., and Anderson G.D. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 67 (1986) 517-522
80. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
81. Sibai B.M., Mabie W.C., Shamsa F., Villar M.A., and Anderson G.D. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162 (1990) 960-966
82. Cunningham F.G., MacDonald P.C., Gant N.F., et al. Endocrine disorders. In: Cunningham F.G., and Whitridge W.J. (Eds). Williams obstetrics. 20th ed. (1997), Appleton & Lange, Stamford, CT 1223-1238
83. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza. Br J Obstet Gynaecol 105 (1998) 718-722
84. Abalos E., Duley L., Steyn D.W., and Henderson-Smart D.J. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 1 (2007) CD002252
85. Magee L.A., and Duley L. Oral beta blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 1 (2003) CD002863
86. Magee L.A., Eltran E., Bull S.B., Logan A., and Koren G. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Redprod Biol 88 (2000) 15-26
87. Management of chronic hypertension during pregnancy. Evidence report/technology assessment, number 14. Agency for Healthcare Research and Quality publication number 00-E010, August 2000 (2000), Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/epcsums/pregsum.htm Available at: www.ahrq.gov/clinic/epcsums/pregsum.htm. Accessed May 5, 2004
88. Magee L.A., Ornstein M.P., and von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 318 (1999) 1332-1336
89. Duley L. Childbirth and pregnancy-pre-eclampsia and hypertension. Clin Evid [online], Issue 9, August 2003 (2003), BMJ Publishing Group, London (United Kingdom). http://clinicalevidence.bmj.com/ceweb/index.jsp Available at: http://clinicalevidence.bmj.com/ceweb/index.jsp. Accessed Aug. 29, 2003
90. Gilstrap L.C., and Ramin S.M. ACOG practice bulletin no. 29: chronic hypertension in pregnancy. Obstet Gynecol 98 (2001) 177-185
91. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program: Working Group Report on High Blood Pressure in Pregnancy (2000), National Heart, Lung, and Blood Institute, Bethesda (MD). http://www.nhlbi.nih.gov/guidelines/archives/hbp_preg/hbp_preg_archive.p df Available at: http://www.nhlbi.nih.gov/guidelines/archives/hbp_preg/hbp_preg_archive.p df. Accessed May 5, 2004
92. Rey E., LeLorier J., Burgess E., Lange I.R., and Leduc L. Report of Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 157 (1997) 1245-1254
93. Neinstein L. Contraception in women with special medical needs. Comp Ther 24 (1998) 229-250
94. Dugowson C.E., Koepsell T.D., Voigt L.F., Bley L., Nelson J.L., and Daling J.R. Rheumatoid arthritis in women. Incidence rates in group health cooperative. Seattle, Washington, 1987-1989. Arthritis Rheum 34 (1991) 1502-1507
95. Da Silva J.A., and Spector T.D. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 11 (1992) 189-194
96. Nelson J.L., Hughes K.A., Smith A.G., Nisperos B.B., Branchaud A.M., and Hansen J.A. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329 (1993) 466
97. Siamopoulou-Mavridou A., Manoussakis M.N., Mavridis A.K., and Moutsopoulos H.M. Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Ann Rheum Dis 47 (1988) 982-987
98. Ostensen M., Forger F., and Villiger P.M. Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci 1069 (2006) 353-363
99. Ostensen M., and Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 26 (1983) 1155-1159
100. Tandon V.R., Sharma S., Mahajan A., Khajuria V., and Kumar A. Pregnancy and rheumatoid arthritis. Indian J Med Sci 60 (2006) 334-344
101. Nelson J.L., Koepsell T.D., Dugowson C.E., Voigt L.F., Daling J.R., and Hansen J.A. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum 36 (1993) 7-14
102. Nelson J.L., Voigt L.F., Koepsell T.D., Dugowson C.E., and Daling J.R. Pregnancy outcome in women with rheumatoid arthritis before disease onset. J Rheumatol 19 (1992) 18-21
103. Nelson J.L., and Ostensen M. Pregnancy and rheumatoid arthritis. Rhem Dis Clin North Am 23 (1997) 195-212
104. Bowden A.P., Barrett J.H., Fallow W., and Silman A.J. Women with inflammatory polyarthritis have babies of lower birth weight. J Rheumatol 28 (2001) 355-359
105. Persellin R.H. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1976- 27 (1977) 922-927
106. Ostensen M., Forger F., and Nelson J.L. Pregnancy in patients with rheumatic disease inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 64 (2005) 839-844
107. Barrett J.H., Brennan P., Fiddler M., and Silman A. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 43 (2000) 1010-1015
108. Chamber C.E., Tutuncu Z.N., Johnson D., and Jones K.L. Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther 8 (2006) 215
109. Temprano K.K., Bandlamudi R., and Moore T.L. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 35 (2005) 112-121
110. Hemandez-Avila M., Liang M.H., Willett W.C., et al. Exogenous sex hormones and the risk of rheumatoid arthritis. Arthrtis Rheum 33 (1990) 947-953
111. Khamashata M.A., and Hughes G.R.V. Pregnancy in systemic lupus erythematosus. Curr Opin Rheumatol 8 (1996) 424-429
112. Mok C.C., and Wong R.W. Pregnancy in systemic lupus erythematosus. Postgrad Med J 77 (2001) 157-165
113. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [Letter]. Arthritis Rheum 40 (1997) 1725
114. Cowchock F.S., Reece E.A., Balaban D., Branch D.W., and Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166 (1992) 1318-1323
115. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 35 (1996) 402-407
116. Zemlickis D., Lishner M., Erlich R., and Koren G. Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen 13 (1993) 139-143
117. Bermas B.L., and Hill J.A. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 38 (1995) 1722-1732
118. Armenti V.T., Ahlswede K.M., Ahlswede B.A., Cater J.R., Moritz M.J., and Burke J.F. National Transplantation Pregnancy Registry: analysis of outcome/risks of 394 pregnancies in kidney transplant recipients. Transplant Proc 26 (1994) 2535
119. Ramsey-Goldman R., Mientus J.M., Kutzer J.E., Mulvihill J.J., and Medsger Jr. T.A. Pregnancy outcomes in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 20 (1993) 1152-1157
120. Armenti V.T., Ahlswede K.M., Ahlswede B.A., Jarrell B.A., Moritz M.J., and Burke J.F. National Transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57 (1994) 502-506
121. Shaheen F.A.M., Al-Sulaiman M.H., and Al-Khader A.A. Long-term nephrotoxicity after exposure to cyclosporine in utero. Transplantation 56 (1993) 224-225
122. Wallace D.J. Antimalarial agents and lupus. Rheum Dis Clin North Am 20 (1994) 243-263
123. Parke A.L., and West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 23 (1996) 1715-1718
124. Parke A.L., and Rothfield N.F. Antimalarial drugs in pregnancy-the North American experience. Lupus 5 Suppl (1996) S67-S69
125. Buchanan N.M., Toubi E., Khamashta M.A., Lima F., Kerslake S., and Hughes G.R. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 55 (1996) 486-488
126. Houser M.T., Fish A.J., Tagatz G.E., Williams P.P., and Michael A.F. Pregnancy and systemic lupus erythematosus. Am J Obstet Gynecol 138 (1980) 409-413
127. Hayslett J.P., and Lynn R.I. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 18 (1980) 207-220
128. Jungers P., Dougados M., Pelissier C., et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 142 (1982) 771-776
129. Bobrie G., Liote F., Houillier P., Grunfeld J.P., and Jungers P. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 9 (1987) 339-343
130. Boumpas D.T., and Balow J.E. Outcome criteria for lupus nephritis trials: a critical overview. Lupus 7 (1998) 622-629
131. Chapel T.A., and Burns R.E. Oral contraceptives and exacerbation of lupus erythematosus. Am J Obstet Gynecol 110 (1971) 366-369
132. Primstone B.L. Systemic erythematosus exacerbated by oral contraceptives. S Afr J Obstet Gynecol 4 (1966) 62-63
133. Furakawa F., Tachibana T., Imamura S., and Tamura T. Oral contraceptive-induced lupus erythematosus in a Japanese woman. J Dermatol 18 (1991) 56-58
134. Garovich M., Agudelo C., and Pisko E. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 23 (1980) 1396-1398
135. Jungers P., Dougados M., Pelissier C., et al. Influence of oral contraceptive therapy on activity of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 618-623
136. Julkunen H.A. Oral contraceptives in systemic lupus erythematosus: side effects and influence on the activity of SLE. Scand J Rheumatol 20 (1991) 427-433
137. Buyon J.P., Kalunian K.C., Skovron M.L., Petri M., Lahita R.G., and Merrill J. Can women with systemic lupus erythematosus safely use exogenous estrogens?. J Clin Rheumatol 1 (1995) 205-212
138. Julkunen H.A., Kaaja R., and Friman C. Contraceptive practice in women with systemic lupus erythematosus. Br J Rheumatol 32 (1993) 227-230
139. Asherson R.A., Harris E.N., Hughes G.R., and Farguharson R.G. Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al. Arthritis Rheum 31 (1988) 575-576
140. Fischer M.J., Lehnerz S.D., Hebert J.R., and Parikh C.R. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis 43 (2004) 415-423
141. Fink J.C., Shwartz, Benedetti T.J., and Stehman-Breen C.O. Increased risk of adverse maternal and infant outcomes among women with renal disease. Paediatr Perinat Epidemiol 12 (1998) 277-287
142. Ramin S.M., Vidaeff A.C., Yeomans E.R., and Gilstrap L.C. Chronic renal disease in pregnancy. Obstet Gynecol 108 (2006) 1531-1539
143. Lindheimer M.D., and Katz A.I. Gestation in women with kidney disease: prognosis and management. Baillieres Clin Obstet Gynaecol 8 (1994) 387-404
144. Jones D.C., and Hayslett J.P. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 335 (1996) 226-232
145. Cunningham F.G., Cox S.M., Harstad T.W., Mason R.A., and Pritchard J.A. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol 163 (1990) 453-459
146. Jungers P., Houllier P., Forget D., and Henry-Amar M. Specific controversies concerning the natural history of renal disease in pregnancy. Am J Kidney Dis 17 (1991) 116-122
147. Abe S. An overview of pregnancy in women with underlying renal disease. Am J Kidney Dis 17 (1991) 112-115
148. Purdy L.P., Hantsch C.E., Molitch M.E., et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 19 (1996) 1067-1074
149. Holley J.L., Bernardini J., Quadri K.H., Greenberg A., and Laifer S.A. Pregnancy outcomes in a prospective matched control study of pregnancy and renal disease. Clin Nephrol 45 (1996) 77-82
150. Epstein F.H. Pregnancy and renal disease [published erratum appears in N Engl J Med 1996;335:759]. N Engl J Med 335 (1996) 277-278
151. Jungers P., Chauveau D., Choukroun G., et al. Pregnancy in women with impaired renal function. Clin Nephrol 47 (1997) 281-288
152. Settler R.W., and Cunningham F.G. Natural history of chronic proteinuria complicating pregnancy. Am J Obstet Gynecol 167 (1992) 1219-1224
153. Burlew B.S. Managing the pregnant patient with heart disease. Clin Cardiol 13 (1990) 757-762
154. Davies G.A.L., and Herbert W.N.P. Heart disease in pregnancy 1: assessment and management of cardiac disease in pregnancy. J Obstet Gynaecol Can 29 (2007) 331-336
155. Koonin L.M., Atrash H.K., Lawson H.W., and Smith J.C. Maternal mortality surveillance, United States, 1979-1986. MMWR Morb Mortal Wkly Rep 40 (1991) 1-13
156. Siu S.C., Sermer M., Colman J.M., Alvarez A.N., et al. Prospective multicentre study of pregnancy outcomes in women with heart disease. Circulation 104 (2001) 515-521
157. Khairy P., Ouyang D.W., Fernandes S.M., Lee-Parritz A., Economy K.E., and Landzberg M.J. Pregnancy outcomes in women with congenital heart disease. Circulation 113 (2006) 517-524
158. Nora J.J., and Nora A.H. Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol 59 (1987) 459-463
159. Hall J.G., Pauli R.M., and Wilson K.M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68 (1980) 122-140
160. American College of Obstetricians and Gynecologists Committee on Practice Bulletins. Obstetrics: thromboembolism in pregnancy. Int J Gynaecol Obstet 75 (2001) 203-212
161. Ressel G.W. American College of Obstetricians and Gynecologists practice bulletin on preventing deep venous thrombosis and pulmonary embolism. Am Fam Physician 63 (2001) 2279-2280
162. Hirsh J., Fuster V., Ansell J., and Halperin J.L. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol 41 (2003) 1633-1652
163. Siu S., and Colman J.M. Cardiovascular problems and pregnancy: an approach to management. Cleveland Clinic J Med 71 (2004) 977-985
164. Shime J., Mocarski E.J., Hastings D., Webb G.D., and McLaughlin P.R. Congenital heart disease in pregnancy: short and long-term implications [published erratum in Am J Obstet Gynecol 1987;156:1361]. Am J Obstet Gynecol 156 (1987) 313-322
165. Whittemore R. Congenital heart disease: its impact on pregnancy. Hosp Pract 18 (1983) 65-74
166. Bonow R.O., Carabello B., de Leon Jr. A.C., et al. American College of Cardiology/American Heart Association guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 32 (1998) 1486-1588
167. Weiss B.M., von Segesser L.K., Alon E., Seifert B., and Turina M.I. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period. 1984-1996. Am J Obstet Gynecol 179 (1998) 1643-1653
168. Weiss B.M., Zemp L., Seifert B., and Hess O. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 31 (1998) 1650-1657
169. Sciscione A.C., and Callan N.A. Pregnancy and contraception. Cardiol Clin 11 (1993) 701-709
170. Cunningham F.G., MacDonald P.C., and Gant N.F. Williams obstetrics. 18th ed. (1989), Appleton & Lange, Norwalk (CT) 984
171. Canobbio M.M., Perloff J.K., and Rapkin A.J. Gynecologic health of females with congenital heart disease. Int J Cardiol 98 (2005) 379-387
172. Bonow R.O., Carabello B.A., Chatterjee K., et al. American College of Cardiology/American Heart Association 2006 practice guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 48 (2006) 600
173. Sibai B.M., How H.Y., and Stella C.L. Thrombophilia in pregnancy: whom to screen, when to treat. OBG Management 19 (2007) 50-64
174. Lee R.M., Brown M.A., Branch D.W., Ward K., and Silver R.M. Anticardiolipin and anti-B2 glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 102 (2003) 294-300
175. Lockwood C.J. Inherited thrombophilias in pregnant patients: Detection and treatment paradigm. Obstet Gynecol 99 (2002) 333-341
176. Silver R.M., and Warren J.E. Preconception counseling for women with thrombophilia. Clin Obstet Gynecol 49 (2006) 906-919
177. Wu O., Robertson L., Twaddle S., et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 10 (2006) 1-110
178. Lin L., and August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105 (2005) 182-192
179. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a metaanalysis. Lancet 361 (2003) 901-908
180. Vossen C.Y., van Korlaar I.M., Cushman M., Rosendall F.R., and Bovill E.G. Sensitivity of a questionnaire for data collection on venous thrombosis. Thromb Res 114 (2004) 259-263
181. Stella C.L., How H.Y., and Sibai B.M. Thrombophilia and adverse maternal-perinatal outcome: Controversies in screening and management. Am J Perinatol 23 (2006) 499-506
182. Robertson L., Wu O., Langhorne P., et al. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
183. Kupferminc M.J., Eldor A., Steinman N., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. (Erratum in: N Engl J Med 1999:341:384). N Engl J Med 340 (1999) 9-13
184. Gris J.C., Quere I., Monpeyroux F., et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haemetologists Study 5 (NOHA5). Thromb Haemost 81 (1999) 891-899
185. DiNisio M., Peters L., and Middledorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev (2005) CD004734
186. Kujovich J.L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 191 (2004) 412-424
187. Barbour L.A., and American College of Obstetricians and Gnecologists Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Thromboembolism in pregnancy. Int J Gynaecol Obstet 75 (2001) 203-212
188. Kwon H.L., Belanger K., and Bracken M.B. Asthmas prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 13 (2003) 317-324
189. Kircher S., Schatz M., and Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol 89 (2002) 463-466
190. Schatz M., Dombrowski M.P., Wise R., et al. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol 112 (2003) 283-288
191. Demissie K., Breckenridge M.B., and Rhodas C.G. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 158 (1998) 1091-1095
192. Liu S., Wen S.W., Demissie K., Marcoux S., and Kramer M.S. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol 184 (2001) 90-96
193. Perlow J.H., Montgomery D., Morgan M.A., Towers C.V., and Porto M. Severity of asthma and perinatal outcome. Am J Obstet Gynecol 167 (1992) 963-967
194. Schatz M., Zeiger R.S., Hoffman C.P., et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med 141 (1995) 1170-1174
195. Jana N., Vasishta K., Saha S.C., and Khunnu B. Effect of bronchial asthma on the course of pregnancy, labour, and perinatal outcome. J Obstet Gynecol 21 (1995) 227-232
196. National Asthma Education and Prevention Program Expert Panel Expert Panel Report: managing asthma during pregnancy: Recommendations for pharmacologic treatment-update 2004. NIH publication 04-5246 (2004), National Institutes of Health, Bethesda, MD
197. Schatz M. The efficacy and safety of asthma medications during pregnancy. Semin Perinatol 25 (2001) 145-152
198. Position statement: the use of newer asthma and allergy medications during pregnancy. American College of Obstetricians and Gynecology, and the American College of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 84 (2000) 475-480
199. Rodriguez-Pinilla E., and Martinel-Frias M.L. Corticosteroids during pregnancy and oral clefts: a case control study. Teratology 56 (1997) 335-340
200. Schatz M., Zeiger R.S., Harden K., Hoffman C.C., Chilingar L., and Petitti D. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 100 (1997) 301-306
201. Schatz M., and Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol 95 (2005) 234-238
202. Kallen B., Rydhstroem H., and Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 93 (1999) 392-395
203. Norjavaara E., and de Verdier M.G. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide. J Allergy Clin Immunol 111 (2003) 735-742